TechNavio's analysts forecast the Global Human Papillomavirus Testing market to grow at a CAGR of 19.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing number of Human Papillomavirus (HPV) cases. The Global Human Papillomavirus Testing market has also been witnessing the trend of increasing the number of mergers and acquisitions. However, lack of sufficient healthcare organizations could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Papillomavirus Testing Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Human Papillomavirus Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Gen-Probe Inc., Hologic Inc., Roche Diagnostic Inc., and QIAGEN N.V.
You can request one free hour of analyst time when you purchase this report. Details provided within the report.